Abstract

Filamentous members of the phylum Actinobacteria are a remarkable source of natural products with pharmaceutical potential. The discovery of novel molecules from these organisms is, however, hindered because most of the biosynthetic gene clusters (BGCs) encoding these secondary metabolites are cryptic or silent and are referred to as orphan BGCs. While co-culture has proven to be a promising approach to unlock the biosynthetic potential of many microorganisms by activating the expression of these orphan BGCs, it still remains an underexplored technique. The marine actinobacterium Salinispora tropica, for instance, produces valuable compounds such as the anti-cancer molecule salinosporamide but half of its putative BGCs are still orphan. Although previous studies have used marine heterotrophs to induce orphan BGCs in Salinispora, its co-culture with marine phototrophs has yet to be investigated. Following the observation of an antimicrobial activity against a range of phytoplankton by S.tropica, we here report that the photosynthate released by photosynthetic primary producers influences its biosynthetic capacities with production of cryptic molecules and the activation of orphan BGCs. Our work, using an approach combining metabolomics and proteomics, pioneers the use of phototrophs as a promising strategy to accelerate the discovery of novel natural products from marine actinobacteria.

Highlights

  • Soil actinomycetes are a rich source of drug-like natural products, to which we owe up to 70% of all microbial antibiotics used today (Berdy, 2012)

  • Microbial Biotechnology published by Society for Applied Microbiology and John Wiley & Sons Ltd

  • We analysed the co-culture supernatants using non-targeted metabolomics to identify the pool of secondary metabolites secreted by S. tropica in response to the different phototrophs

Read more

Summary

Introduction

Soil actinomycetes are a rich source of drug-like natural products, to which we owe up to 70% of all microbial antibiotics used today (Berdy, 2012). Identification of novel secondary metabolites from this extensively studied phylum has, stalled over the last few decades as a result of the recurring rediscovery of already known compounds. Despite the increasing number of novel strains identified with promising biosynthetic capacities, many hurdles in natural product discovery remain Most of these microbial secondary metabolites are encoded by groups of colocalized genes, called biosynthetic gene clusters (BGCs), which are more identified because of the improvement in sequencing technologies and bioinformatic tools (Medema et al, 2011).

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call